J&J Files 8-K Detailing Debt Maturities

Ticker: JNJ · Form: 8-K · Filed: 2025-04-03T00:00:00.000Z

Sentiment: neutral

Topics: debt, financials, disclosure

Related Tickers: JNJ

TL;DR

JNJ filed an 8-K showing all their debt maturities and interest rates through 2055.

AI Summary

Johnson & Johnson filed an 8-K on April 3, 2025, reporting on its financial statements and exhibits as of March 31, 2025. The filing details various notes with different maturity dates and interest rates, including "A1.150 Notes Due November 2028" and "A3.700 Notes Due February 2055". This filing serves as a regulatory disclosure.

Why It Matters

This filing provides investors with a clear overview of Johnson & Johnson's outstanding debt obligations, including specific interest rates and maturity dates, which is crucial for assessing the company's financial structure and long-term liabilities.

Risk Assessment

Risk Level: low — This is a routine financial disclosure filing with no new material events or changes in risk factors.

Key Players & Entities

FAQ

What is the total principal amount of the debt detailed in this filing?

The filing does not explicitly state the total principal amount of all debt, but lists various notes with specific maturity dates and interest rates.

When was this 8-K form filed with the SEC?

This 8-K form was filed on April 3, 2025.

What is the earliest maturity date for the debt instruments listed?

The earliest maturity date listed is November 2028 for the 'A1.150 Notes Due November 2028'.

What is the latest maturity date for the debt instruments listed?

The latest maturity date listed is February 2055 for the 'A3.700 Notes Due February 2055'.

What specific items are being reported in this 8-K filing?

This 8-K filing reports on Regulation FD Disclosure and Financial Statements and Exhibits as of March 31, 2025.

From the Filing

0000200406-25-000106.txt : 20250403 0000200406-25-000106.hdr.sgml : 20250403 20250403164302 ACCESSION NUMBER: 0000200406-25-000106 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 17 CONFORMED PERIOD OF REPORT: 20250331 ITEM INFORMATION: Regulation FD Disclosure ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250403 DATE AS OF CHANGE: 20250403 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JOHNSON & JOHNSON CENTRAL INDEX KEY: 0000200406 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 221024240 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1229 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-03215 FILM NUMBER: 25810272 BUSINESS ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 BUSINESS PHONE: 732-524-2455 MAIL ADDRESS: STREET 1: ONE JOHNSON & JOHNSON PLZ CITY: NEW BRUNSWICK STATE: NJ ZIP: 08933 8-K 1 jnj-20250331.htm 8-K jnj-20250331 0000200406 false 0000200406 2025-03-31 2025-03-31 0000200406 us-gaap:CommonStockMember 2025-03-31 2025-03-31 0000200406 jnj:A1.150NotesDueNovember2028Member 2025-03-31 2025-03-31 0000200406 jnj:A2.700NotesDueFebruary2029Member 2025-03-31 2025-03-31 0000200406 jnj:A3.20NotesDueNovember2032Member 2025-03-31 2025-03-31 0000200406 jnj:A3.050NotesDueFebruary2033Member 2025-03-31 2025-03-31 0000200406 jnj:A1.650NotesDue2035Member 2025-03-31 2025-03-31 0000200406 jnj:A3.350NotesDueNovember2036Member 2025-03-31 2025-03-31 0000200406 jnj:A3.350NotesDueFebruary2037Member 2025-03-31 2025-03-31 0000200406 jnj:A3.550NotesDueNovember2044Member 2025-03-31 2025-03-31 0000200406 jnj:A3.600NotesDueFebruary2045Member 2025-03-31 2025-03-31 0000200406 jnj:A3.700NotesDueFebruary2055Member 2025-03-31 2025-03-31 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM  8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of report (Date of earliest event reported):  March 31, 2025 Johnson & Johnson (Exact name of registrant as specified in its charter) New Jersey 1-3215 22-1024240 (State or Other Jurisdiction of Incorporation) (Commission File Number) (IRS Employer Identification No.) One Johnson & Johnson Plaza , New Brunswick , New Jersey    08933   (Address of Principal Executive Offices)  (Zip Code)  Registrant's telephone number, including area code: 732 - 524-0400 Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))  ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ SECURITIES REGISTERED PURSUANT TO SECTION 12(b) OF THE ACT Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, Par Value $1.00 JNJ New York Stock Exchange 1.150% Notes Due November 2028 JNJ28 New York Stock Exchange 2.700% Notes due February 2029 JNJ29B New York Stock Exchange 3.20% Notes Due November 2032 JNJ32 New York Stock Exchange 3

View on Read The Filing